Hyderabad (Telangana) [India], December 24 (ANI): Aurobindo Pharma and US-based Covaxx have entered into a license agreement to develop, commercialise and manufacture a vaccine to fight Covid-19 for India and the United Nations Children's Fund (UNICEF) agency.
Gurugram (Haryana) [India], December 23 (ANI): Haryana Home and Health Minister Anil Vij, who is undergoing treatment for COVID-19, has been shifted from the Intensive Care Unit (ICU) to a room on Wednesday.
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
Chandigarh/Gurugram (Haryana) [India], December 21 (ANI): Haryana Home and Health Minister, Anil Vij, who is undergoing treatment for Covid-19 continues to make steady progress.
New Delhi [India], December 20 (ANI): India may begin vaccinating people against COVID-19 in January and the government's first priority has been safety and efficacy of the vaccine, Union Health Minister Harsh Vardhan has said.
Chandigarh/Gurugram (Haryana) [India], December 18 (ANI): Haryana Home and Health Minister Anil Vij, who is undergoing treatment for COVID-19 at Medanta hospital in Gurugram, had restful sleep last night, according to a medical bulletin issued by the hospital on Friday.
Phnom Penh [Cambodia], December 18 (ANI): Cambodian Prime Minister Hun Sen hit out at China saying the country is not a dumping ground for Beijing in terms of vaccine trial" adding that the first batch of COVID-19 vaccines will come from the UN-backed COVAX.
New Delhi [India], December 16 (ANI): No serious adverse effect related to the vaccine has been reported by COVID-19 vaccine (BBV152) COVAXIN, the interim finding from the phase 1 clinical trial of COVAXIN has stated which has now been published in the pre-print version on Monday.
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' has been referred to Medanta Hospital Gurugram on Tuesday.
Hyderabad (Telangana) [India], December 9 (ANI): Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
New Delhi [India], December 8 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India.